United States. Congress

“ Qualifying enrollee.—The term ‘qualifying enrollee’ means an individual enrolled in a prescription drug plan or MA–PD plan other than such an individual who is a subsidy-eligible individual (as defined in section 1860D–14 (a) (3) ) . `` (C) Drug-component negotiated price.—The term ‘drug-component negotiated price’ means, with respect to a qualifying drug, the negotiated price (as defined in subsection (d) (1) (B) ) , as determined without regard to any dispensing fee, of the drug under the prescription drug plan or MA–PD plan involved. ”

“ Cumulative phase-in percentage.—The term ‘cumulative phase-in percentage’ means for a year the sum of the annual phase-in percentage for the year and the annual phase-in percentages for each previous year beginning with 2011, but in no case more than 100 percent. ”

“ Prescription drug rebate agreement for full-Benefit dual eligible individuals.— `` (1) In general.—In this part, the term ‘covered part D drug’ does not include any drug or biologic that is manufactured by a manufacturer that has not entered into and have in effect a rebate agreement described in paragraph (2) . ”